Kelly Stone
About Kelly Stone
Kelly Stone is a Medical Science Liaison at Novocure Inc. with 18 years of experience in various therapeutic areas and extensive expertise in Transfusion Medicine, Hematology, Serology, and Clinical Chemistry.
Company
Kelly Stone is currently employed at Novocure Inc., holding the role of Medical Science Liaison in the Southwest region.
Title
Kelly Stone serves as a Medical Science Liaison, bringing substantial experience and expertise in various therapeutic areas such as Hematology, Pathology, and Oncology.
Education and Expertise
Kelly Stone studied at Tarleton State University. Over the years, Stone has acquired extensive knowledge in Transfusion Medicine, Hematology, Serology, and Clinical Chemistry. Notably, Stone has significant experience in in-vitro diagnostic testing and has collaborated with research clinicians on studies involving FDA non-approved assays and instrumentation for 510K submission.
Professional Background
Kelly Stone has held several key positions in the medical field. Prior to joining Novocure Inc., Stone worked at Discovery Labs as a Medical Science Liaison in Texas in 2015. Stone also served as Director, Global Health Science - Medical Science Liaison at The Medicines Company from 2013 to 2014. From 2010 to 2013, Stone was a Senior Medical Science Liaison at ZymoGenetics, a Bristol-Myers Squibb Company, and held a similar role from 2007 to 2010. Earlier in the career, Stone worked at Diagnostica Stago as a Scientific Specialist from 1996 to 1998, and at the American Red Cross as a Medical Science Liaison from 1990 to 1996.
Achievements
Boasting 18 years of experience as a Medical Science Liaison, Kelly Stone has expertise encompassing multiple therapeutic areas, including Surgical Hemostasis, Coagulation, Hemophilia, Hypertension, Pain Management, and Oncology. Additionally, Stone contributed to studies with FDA non-approved assays and instrumental in collaboration with research clinicians, focusing on 510K submissions.